Unique ID issued by UMIN | UMIN000051061 |
---|---|
Receipt number | R000058225 |
Scientific Title | Evaluation study for intake of cyclic dipeptide on improvements in cognitive function |
Date of disclosure of the study information | 2023/05/22 |
Last modified on | 2023/05/15 15:08:57 |
Evaluation study for intake of cyclic dipeptide on improvements in cognitive function
Evaluation study for intake of cyclic dipeptide on improvements in cognitive function
Evaluation study for intake of cyclic dipeptide on improvements in cognitive function
Evaluation study for intake of cyclic dipeptide on improvements in cognitive function
Japan |
Healthy adults
Adult |
Others
NO
To evaluate improvements in cognitive function by taking cyclic dipeptide
Safety,Efficacy
RBANS
Cognitrax
(before and 12 weeks after intake)
SF-36v2
WHO-5J
body mass and BMI
blood pressure, pulsation
subjects' diary
doctor's questions
(before and 12 weeks after intake)
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Treatment
Food |
Intake cyclic dipeptide for 12 weeks
Intake placebo for 12 weeks
60 | years-old | <= |
75 | years-old | >= |
Male and Female
1) Japanese males and females aged 60 to 75 years oldĀ at the time of informed consent
2) Subjects who feel that they are more forgetful compared with their younger days
1) Subjects judged inappropriate for the study by the principal
2) Subjects who are participating in other clinical trials
3) Subjects who are taking medicines that can affect the test result
4) Subjects who are taking supplements that can affect the test result
5) Subjects who took RBANS by 3 months before the start of the test
6) Subjects who can be allergic to the test food
7) Subjects who have had a stroke, subarachnoid hemorrhage, cerebral infarction, cerebral hemorrhage, cerebral contusion, or head injury resulting in hospitalization for treatment or surgery
8) Excessive tobacco and alcohol users and those with extremely irregular eating habits
9) Subjects with medical history of hepatitis
10) Subjects with severe anemia
11) Subjects with medical history or medical treatments of Epileptic seizures, diabetes, thyroid dysfunction, or severe renal dysfunction (hemodialysis, uremia, anuria)
12) Subjects who have taken neuropsychological tests in the hospital
60
1st name | Takashi |
Middle name | |
Last name | Koikeda |
Shiba Palace Clinic
Chair
105-0013
DaiwaA Hamamatsucho Bldg. 6F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, JAPAN
03-5408-1590
jimukyoku@mail.souken-r.com
1st name | Miwa |
Middle name | |
Last name | Kaneko |
SOUKEN Co., Ltd
Management Division
105-0013
DaiwaA Hamamatsucho Bldg. 3F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, JAPAN
03-5408-1555
m_kaneko@mail.souken-r.com
Shiba Palace Clinic
JELLICE
Profit organization
Shiba Palace Clinic Ethics Review Committee
DaiwaA Hamamatsucho Bldg. 6F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, JAPAN
03-5408-1599
shiba_palace@s-palace-clinic.com
NO
2023 | Year | 05 | Month | 22 | Day |
Unpublished
Open public recruiting
2023 | Year | 04 | Month | 27 | Day |
2023 | Year | 05 | Month | 11 | Day |
2023 | Year | 05 | Month | 15 | Day |
2023 | Year | 11 | Month | 30 | Day |
2023 | Year | 05 | Month | 15 | Day |
2023 | Year | 05 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058225
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |